Payer PolicyActive
CG-THER-RAD-07 Intravascular Coronary and Non-Coronary Brachytherapy
ANTHEM-GL-D080210
Anthem
Effective: January 30, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses intravascular brachytherapy (radiation delivered inside blood vessels), specifically intravascular coronary brachytherapy (ICB) for treating in-stent restenosis. ICB is covered only when used for coronary in-stent restenosis in individuals with persistent myocardial ischemia symptoms despite guideline-directed medical therapy or who have a contraindication to such therapy. It is not covered for any other coronary indications when these criteria are not met, and intravascular non-coronary brachytherapy is not covered for any indication.
Coverage Criteria Preview
Key requirements from the full policy
"Intravascular coronary brachytherapy is consideredmedically necessaryas a treatment of in-stent restenosis when individuals have persistent symptoms of myocardial ischemia despite guideline-directe..."
Sign up to see full coverage criteria, indications, and limitations.